4180 Mendenhall Oaks Parkway
High Point, NC 27265, USA
Tel: +1 336-841-5250
Fax: +1 336-841-5251
From our site in High Point, North Carolina, USA, we develop, manufacture and scale-up small molecule APIs and intermediates to support clinical trials from Phase I to Phase III.
Home to a team of more than 60 employees, the site has a 15,000 sq. ft. chemistry laboratory and a 13,000 sq. ft. pilot plant, with reactor capacity ranging from 20L to 2000L.
Our team of PhD level Process and Analytical Chemists offer GMP analytical services.
Our site is licensed with the US Drug Enforcement Administration (DEA) to manufacture Schedule II to Schedule V controlled substances.